Cookson Peirce & CO Inc Ardelyx, Inc. Transaction History

Cookson Peirce & CO Inc

  • $2.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$6.05 - $9.74 $55,502 - $89,354
-9,174 Reduced 30.58%
20,826 $152,000
Q4 2023

Jan 30, 2024
BUY
$3.29 - $6.64 $98,700 - $199,200
30,000 New
30,000 $186,000
Q1 2023

May 03, 2023
BUY
$2.68 - $4.79 $134,000 - $239,500
50,000 New
50,000 $240,000

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email